Results 211 to 220 of about 1,240,122 (231)

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Brain Metastases Working Group.

Journal of Clinical Oncology, 2017
N. Lin, Tatiana M. Prowell, A. Tan, Marina Kozak, O. Rosen, L. Amiri-Kordestani, J. White, J. Sul, Louise Perkins, K. Beal, Richard B. Gaynor, Edward S. Kim   +11 more
semanticscholar   +1 more source

Involving children and young people in clinical research through the forum of a European Young Persons’ Advisory Group: needs and challenges

Fundamental & Clinical Pharmacology, 2018
S. Gaillard, S. Malik, J. Preston, B. Escalera, P. Dicks, N. Touil, S. Mardirossian, Joana Claverol‐Torres, B. Kassaï   +8 more
semanticscholar   +1 more source

Discriminating clinical phases of recovery from major depressive disorder using the dynamics of facial expression

Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2016
Sahar Harati, A. Crowell, H. Mayberg, Jun Kong, S. Nemati   +4 more
semanticscholar   +1 more source

Phase II trial of cisplatin for adenocarcinoma of unknown primary site. IKZ/IKO Clinical Research Group.

European journal of cancer (Oxford, England : 1990), 1991
The activity of cisplatin against advanced metastatic adenocarcinoma of unknown primary site (ACUP) was evaluated in 21 patients. Cisplatin (100 mg/m2) was given as a 4-h continuous infusion every 3 weeks, with appropriate fluids and diuretics. The overall response rate was 19% with 1 complete remission for 12 months and 3 partial remissions lasting ...
D J, Wagener, P H, de Mulder, J T, Burghouts, J J, Croles   +3 more
openaire   +1 more source

Neonatal hypoxic–ischemic encephalopathy: emerging therapeutic strategies based on pathophysiologic phases of the injury

Journal of Maternal-Fetal & Neonatal Medicine, 2019
Qiu-li Wang, H. Lv, Lixin Lu, Peng-shun Ren, Lian-xiang Li   +4 more
semanticscholar   +1 more source

On replicating studies, phase II and phase III trials, and other vagaries of clinical research

Community Oncology, 2011
David L. Streiner, Geoffrey R. Norman
openaire   +1 more source

Phases of Progressive Burnout and Their Work Site Covariants: Critical Issues in OD Research and Praxis

Journal of Applied Behavioral Science, 1983
R. Golembiewski, R. Munzenrider, Diane Carter   +2 more
semanticscholar   +1 more source

Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?

Gene Therapy, 2001
D. Kirn
semanticscholar   +1 more source

Informed consent in clinical research in France: assessment and factors associated with therapeutic misconception

Journal of Medical Ethics, 2008
I. Durand-zaleski, C. Alberti, P. Durieux, X. Duval, S. Gottot, P. Ravaud, S. Gainotti, Claire Vincent-Genod, D. Moreau, P. Amiel   +9 more
semanticscholar   +1 more source

Importance and Challenges of Studying Marketed Drugs: What Is a Phase IV Study? Common Clinical Research Designs, Registries, and Self‐Reporting Systems

Journal of clinical pharmacology, 2007
S. Glasser, M. Salas, E. Delzell
semanticscholar   +1 more source